Position history for Temasek Holdings (Private) Ltd's holdings in DENALI THERAPEUTICS INC
Temasek Holdings (Private) Ltd holds 7M shares of DNLI (DENALI THERAPEUTICS INC), worth $134.6M as of 2026-Q1. DNLI represents 0.4% of Temasek Holdings (Private) Ltd's portfolio.
Current Value
$134.6M
Current Shares
7M
Total Value Change
+$2.1M
Total Shares Change
+1.3M
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 7M |
0.0% |
| $134.6M |
| 0.4% |
| $20.02 |
0 |
| 2025-Q4 | Increased | 7M | +30.9% | $115.8M | 0.4% | $16.41 | 46 |
| 2025-Q3 | Unchanged | 5.4M | 0.0% | $77.8M | 0.3% | $14.52 | 0 |
| 2025-Q2 | Unchanged | 5.4M | 0.0% | $74.9M | 0.3% | $14.10 | 0 |
| 2025-Q1 | Unchanged | 5.4M | 0.0% | $72.8M | 0.3% | $14.78 | 0 |
| 2024-Q4 | Unchanged | 5.4M | 0.0% | $109.2M | 0.4% | $20.24 | 0 |
| 2024-Q3 | Decreased | 5.4M | -6.1% | $156M | 0.6% | $29.43 | 0 |
| 2024-Q2 | Unchanged | 5.7M | 0.0% | $132.5M | 0.6% | $23.22 | 0 |